Bridgebio Pharma, Inc. · NASDAQ:BBIO

KKR Genetic Disorder L.P. reported a 10.10% stake in Bridgebio Pharma, Inc. (Schedule 13D/A)

Event Mar 5, 2025 · Filed Mar 7, 2025

KKR Genetic Disorder L.P. reported a 10.10% stake in Bridgebio Pharma, Inc., 19,260,971 shares, with active intent on Mar 5, 2025. Filed Mar 7, 2025 (Schedule 13D/A).

Stake
10.10%
Shares
19,260,971
Intent
Active
What changed
Stake changed
Filed together
9 holders

The filing in full

HolderStakeShares
KKR Genetic Disorder L.P.10.10%19,260,971
KKR Genetic Disorder GP LLC10.10%19,260,971
KKR Group Partnership L.P.10.10%19,260,971
KKR Group Holdings Corp.10.10%19,260,971
KKR Group Co. Inc.10.10%19,260,971
KKR & Co. Inc.10.10%19,260,971
KKR Management LLP10.10%19,260,971
Henry R. Kravis10.10%19,260,971
George R. Roberts10.10%19,260,971

Source

View original at SEC

Related